|
6 Companies |
|
2 Products |
|
2 Products |
|
0 Mechanisms of Action |
|
0 Trials |
|
35 News |
|
- | Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion: A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot (clinicaltrials.gov) - Jun 2, 2018
P=N/A, N=36, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: Plantar Forces Mid-term After Hemiarthroplasty With HemiCap for Hallux Rigidus (clinicaltrials.gov) - Nov 28, 2017
P=N/A, N=41, Completed, Sponsor: Copenhagen University Hospital, Hvidovre
Active, not recruiting --> Completed Recruiting --> Completed | N=90 --> 41 | Trial primary completion date: Nov 2016 --> Feb 2017
- | Xeomin (incobotulinumtoxinA) / Merz Pharma, Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
Trial completion: Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot (clinicaltrials.gov) - Oct 20, 2017
P4, N=20, Completed, Sponsor: Parc de Salut Mar
Recruiting --> Completed | N=90 --> 41 | Trial primary completion date: Nov 2016 --> Feb 2017 Recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: Clubfoot DNA Repository (clinicaltrials.gov) - May 9, 2017
P=N/A, N=379, Completed, Sponsor: Texas Scottish Rite Hospital for Children
Recruiting --> Completed Recruiting --> Completed | N=500 --> 379 | Trial primary completion date: Jan 2018 --> May 2017
- Xeomin (incobotulinumtoxinA) / Merz Pharma, Botox (onabotulinumtoxin A) / GSK, AbbVie, Healis Therap
New P4 trial: Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot (clinicaltrials.gov) - Feb 6, 2017
P4, N=20, Recruiting, Sponsor: Parc de Salut Mar
- |||| Xeomin (incobotulinumtoxinA) / Merz Pharma
Trial completion: XEBEC: Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy (clinicaltrials.gov) - Jan 26, 2017
P2, N=64, Completed, Sponsor: Merz Pharmaceuticals GmbH
Recruiting --> Completed | N=500 --> 379 | Trial primary completion date: Jan 2018 --> May 2017 Active, not recruiting --> Completed
- ||| Xeomin (incobotulinumtoxinA) / Merz Pharma
Enrollment closed: XEBEC: Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy (clinicaltrials.gov) - Dec 21, 2016
P2, N=64, Active, not recruiting, Sponsor: Merz Pharmaceuticals GmbH
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Exparel (bupivacaine liposome injectable suspension) / Pacira
Enrollment change, Trial termination, Trial primary completion date, Surgery: Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=2, Terminated, Sponsor: OhioHealth
Recruiting --> Active, not recruiting N=50 --> 2 | Recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Jan 2016; Logistical issues prevent efficient enrollment
- New trial: Polyaxial Brace Fixing for the Treatment of Congenital Clubfoot (clinicaltrials.gov) - Jun 28, 2016
P=N/A, N=88, Completed, Sponsor: Children's Hospital of Chongqing Medical University
- Enrollment change, Trial withdrawal: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession (clinicaltrials.gov) - Mar 29, 2016
P=N/A, N=0, Withdrawn, Sponsor: OhioHealth
N=50 --> 2 | Recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Jan 2016; Logistical issues prevent efficient enrollment N=48 --> 0 | Recruiting --> Withdrawn
- || Xeomin (incobotulinumtoxinA) / Merz Pharma
Trial primary completion date: XEBEC: Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy (clinicaltrials.gov) - Jan 22, 2016
P2, N=64, Recruiting, Sponsor: Merz Pharmaceuticals GmbH
N=48 --> 0 | Recruiting --> Withdrawn Trial primary completion date: Dec 2015 --> Dec 2016
- Trial completion, MRI: Exploring the Causes of Clubfoot Using Magnetic Resonance Imaging, MRI (clinicaltrials.gov) - Nov 9, 2015
P=N/A, N=35, Completed, Sponsor: University of Aberdeen
Trial primary completion date: Dec 2015 --> Dec 2016 Not yet recruiting --> Completed
- Enrollment open, Trial initiation date: Instep Plantar Fasciotomy With and Without Gastrocnemius Recession (clinicaltrials.gov) - Oct 7, 2015
P=N/A, N=48, Recruiting, Sponsor: OhioHealth
Not yet recruiting --> Completed Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> May 2014
- Exparel (bupivacaine liposome injectable suspension) / Pacira
New trial, Surgery: Pericapsular Exparel for Pain Relief in Bunionectomy and Related Procedures (clinicaltrials.gov) - Jul 16, 2015
P=N/A, N=50, Recruiting, Sponsor: OhioHealth
- Enrollment change, Trial termination, Trial primary completion date: A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3 (clinicaltrials.gov) - Apr 14, 2015
P4, N=1, Terminated, Sponsor: RTI Biologics
Not yet recruiting --> Recruiting | Initiation date: Dec 2014 --> May 2014 N=24 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Jan 2015; slow recruitment
- Clinical: A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants (clinicaltrials.gov) - Mar 20, 2015
P=N/A, N=65, Completed, Sponsor: Shriners Hospitals for Children
- ||| Clinical: A Post-Marketing Observational Study to Evaluate Primus™ FGT Implant at a Minimum of 5 Years Follow-up (clinicaltrials.gov) - Jan 30, 2015
P=N/A, N=70, Completed, Sponsor: Tornier
- Trial completion, Enrollment change, Surgery: Neuro-orthopaedic Surgery in the Treatment of the Spastic Equinovarus Foot (clinicaltrials.gov) - Jan 2, 2015
P=N/A, N=22, Completed, Sponsor: University Hospital of Mont-Godinne
N=24 --> 1 | Recruiting --> Terminated | Trial primary completion date: Jun 2016 --> Jan 2015; slow recruitment Recruiting --> Completed | N=50 --> 22
- Trial completion, Compliance: Outcomes of Compliance With Brace Wear in Clubfoot (clinicaltrials.gov) - Nov 24, 2014
P=N/A, N=67, Completed, Sponsor: Shriners Hospitals for Children
Recruiting --> Completed | N=50 --> 22 Recruiting --> Completed
- ||||| Xeomin (incobotulinumtoxinA) / Merz Pharma
New P2 trial: XEBEC: Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy (clinicaltrials.gov) - Jul 12, 2014
P2, N=64, Recruiting, Sponsor: Merz Pharmaceuticals GmbH
- | New P4 trial: A Clinical Study of Outcomes in Foot and Ankle Bone Grafting Using map3 (clinicaltrials.gov) - Jun 12, 2014
P4, N=24, Recruiting, Sponsor: RTI Biologics
- || Enrollment change: Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=60, Completed, Sponsor: Integra LifeSciences Services
Recruiting --> Completed N=115 --> 60
- ||| Trial completion: Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS (clinicaltrials.gov) - Dec 10, 2013
P=N/A, N=60, Completed, Sponsor: Integra LifeSciences Services
N=115 --> 60 Active, not recruiting --> Completed
- Trial withdrawal: A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes (clinicaltrials.gov) - Dec 2, 2013
P4, N=0, Withdrawn, Sponsor: Susan Hassenbein
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- Enrollment change: A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes (clinicaltrials.gov) - Dec 2, 2013
P4, N=0, Withdrawn, Sponsor: Susan Hassenbein
Not yet recruiting --> Withdrawn N=200 --> 0
- New P4 trial: A Prospective Randomized Comparison of Three Methods for Fixation of Hammertoes (clinicaltrials.gov) - Aug 21, 2013
P4, N=0, Withdrawn, Sponsor: Susan Hassenbein
- Trial termination: Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial (clinicaltrials.gov) - Aug 7, 2013
P=N/A, N=40, Terminated, Sponsor: Dynasplint Systems, Inc.
N=200 --> 0 Recruiting --> Terminated; Unrelated to Trial
- Enrollment change: Contracture Reduction Following Bunionectomy: a Longitudinal, Controlled Trial (clinicaltrials.gov) - Aug 7, 2013
P=N/A, N=40, Terminated, Sponsor: Dynasplint Systems, Inc.
Recruiting --> Terminated; Unrelated to Trial N=110 --> 40
- Trial termination: Ankle Equinus Contracture Treated With Dynamic Splinting (clinicaltrials.gov) - Jul 9, 2013
P=N/A, N=15, Terminated, Sponsor: Dynasplint Systems, Inc.
N=110 --> 40 Recruiting --> Terminated; Centers could not meet enrollment goals
- Enrollment change: Ankle Equinus Contracture Treated With Dynamic Splinting (clinicaltrials.gov) - Jul 9, 2013
P=N/A, N=15, Terminated, Sponsor: Dynasplint Systems, Inc.
Recruiting --> Terminated; Centers could not meet enrollment goals N=50 --> 15
- Trial completion: Efficacy Study of Selective Tibial Neurotomy in the Treatment of the Spastic Equinovarus Foot Among Adult Hemiplegic Patients (clinicaltrials.gov) - Dec 21, 2011
P3, N=16, Completed, Sponsor: Cliniques universitaires Saint-Luc- Universit
N=50 --> 15 Active, not recruiting --> Completed
- Compliance: Outcomes of Compliance With Brace Wear in Clubfoot (clinicaltrials.gov) - Nov 14, 2011
P=N/A, N=70, Recruiting, Sponsor: Shriners Hospitals for Children
- Enrollment change: Surgical Treatment for Hallux Rigidus (clinicaltrials.gov) - Aug 17, 2011
P=N/A, N=158, Completed, Sponsor: American College of Foot and Ankle Surgeons
Active, not recruiting --> Completed N=300 --> 158
- Trial completion: Surgical Treatment for Hallux Rigidus (clinicaltrials.gov) - Aug 17, 2011
P=N/A, N=158, Completed, Sponsor: American College of Foot and Ankle Surgeons
N=300 --> 158 Recruiting --> Completed